548 Results

People

  1. Rossi
    Rossi
  2. Dee
    Dee
  3. Marghoob
    Marghoob
  4. Dogan
    Dogan
  5. Dusza
    Dusza
  6. Giralt
    Giralt
  7. Perales
    Perales
  8. Marchetti
    Marchetti
  9. Nehal
    Nehal
  10. Salles
    Salles

Groups

  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)
  7. Population Sciences Research Program (116)
  8. GSK Faculty (96)
  9. Dermatology Service (87)
  10. Dermatology (86)
  1. "Research letter"
Formats
  1. Research Letter (548)
Groups
  1. Department of Medicine (301)
  2. Hematologic Malignancies, Division of (169)
  3. Center for Hematologic Malignancies (151)
  4. Sloan Kettering Institute Postdocs (133)
  5. Survivorship Research (132)
  6. Division of Subspecialty Medicine (121)

More Groups

People
  1. Anthony Rossi (23)
  2. Edward Christopher Dee (21)
  3. Ashfaq Marghoob (19)
  4. Ahmet Dogan (18)
  5. Michael Marchetti (18)
  6. Miguel-Angel Perales (17)

More People

Years
  1. 2025 (42)
  2. 2024 (89)
  3. 2023 (101)
  4. 2022 (82)
  5. 2021 (91)
  6. 2020 (95)

More Years

Publications
  1. Journal of the American Academy of Dermatology (46)
  2. Blood Advances (31)
  3. Haematologica (25)
  4. Leukemia (25)
  5. Bone Marrow Transplantation (18)
  6. American Journal of Hematology (17)

More Publications

Publishers
  1. Nature Publishing Group (97)
  2. Mosby Elsevier (49)
  3. American Medical Association (45)
  4. American Society of Hematology (44)
  5. Wiley Blackwell (34)
  6. Elsevier Inc. (29)

More Publishers

Results (548)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease
    Research Letter

    Smits, B. M.; Lelieveld, P. H. C.; Ververs, F. A.; Turkenburg, M.; de Koning, C.; van Dijk, M.; Leavis, H. L.; Boelens, J. J.; Lindemans, C. A.; Bloem, A. C.; more...
    Clinical Immunology (2020)

    Fulltext@MSK | Save
  • RAS pathway influences the number of melanocytic nevi in cardiofaciocutaneous and Costello syndromes
    Research Letter

    Kiuru, M.; Urban, J.; Zhu, G.; Rybak, I.; Terrell, J. R.; Qi, L.; McPherson, J. D.; Marghoob, A. A.; Rauen, K. A.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • Retrospective case series of isotretinoin outcomes for acne in 393 female patients at Baylor College of Medicine during 2012-2016
    Research Letter

    Fernandez, J.; Lee, B.; Patel, J. M.; Weiss, E.; Jiang, J.; Dao, H.; Kim, S. J.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • Mentorship in radiation oncology: Role of gender diversity in abstract presenting and senior author dyads on subsequent high-impact publications
    Research Letter

    Lee, A.; Albert, A.; Griffith, K.; Evans, S.; Rahimy, E.; Park, H. S.; Cervino, L. I.; Moran, J. M.; Jagsi, R.
    Advances in Radiation Oncology (2020)

    Fulltext@MSK | Save
  • KDM4A regulates the maternal-to-zygotic transition by protecting broad H3K4me3 domains from H3K9me3 invasion in oocytes
    Research Letter

    Sankar, A.; Lerdrup, M.; Manaf, A.; Johansen, J. V.; Gonzalez, J. M.; Borup, R.; Blanshard, R.; Klungland, A.; Hansen, K.; Andersen, C. Y.; more...
    Nature Cell Biology (2020)

    Fulltext@MSK | Save
  • Vorasidenib (AG-881): A first-in-class, brain-penetrant dual inhibitor of mutant IDH1 and 2 for treatment of glioma
    Research Letter

    Konteatis, Z.; Artin, E.; Nicolay, B.; Straley, K.; Padyana, A. K.; Jin, L.; Chen, Y.; Narayaraswamy, R.; Tong, S.; Wang, F.; more...
    ACS Medicinal Chemistry Letters (2020)

    Fulltext@MSK | Save
  • Inherited melanoma risk variants associated with histopathologically amelanotic melanoma
    Research Letter

    Gibbs, D. C.; Orlow, I.; Vernali, S.; Powell, H. B.; Kanetsky, P. A.; Luo, L.; Busam, K. J.; Sharma, A.; Kricker, A.; Armstrong, B. K.; more...
    Journal of Investigative Dermatology (2020)

    Fulltext@MSK | Save
  • Clinician vs patient reporting of baseline and postbaseline symptoms for adverse event assessment in cancer clinical trials
    Research Letter

    Atkinson, T. M.; Dueck, A. C.; Satele, D. V.; Thanarajasingam, G.; Lafky, J. M.; Sloan, J. A.; Basch, E.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Characterizing relative and disease-specific survival in early-stage cancers
    Research Letter

    Marcadis, A. R.; Marti, J. L.; Ehdaie, B.; Hakimi, A. A.; Davies, L.; Morris, L. G. T.
    JAMA Internal Medicine (2020)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in non-small-cell lung cancer - The authors' reply
    Research Letter

    Hellmann, M. D.; Ramalingam, S. S.
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save